Milnacipran Press Articles
Business Wire - Forest Laboratories, Inc. Reports Fiscal Year Second Quarter 2012 Earnings Per Share of $0.91
Posted by admin / Under MilnacipranOctober 18, 2011 --
NEW YORK -- Forest Laboratories, Inc. (NYSE: FRX), an international pharmaceutical manufacturer and marketer, today announced that...
Published on Wednesday 8th of February 2012 01:03:03 PM
Read more...
Business Wire - Research and Markets: Milnacipran - Comprehensive Patent Search
Posted by admin / Under MilnacipranFebruary 14, 2011 -- HASH(0x19766610)
DUBLIN -- Research and Markets (
Published on Wednesday 8th of February 2012 01:03:03 PM
Read more...
Business Wire - Forest Laboratories Enters Collaboration on Bystolic® and Savella® in Canada
Posted by admin / Under MilnacipranNovember 11, 2010 -- HASH(0x17fa7040)
NEW YORK -- Forest Laboratories, Inc. (Forest) (NYSE: FRX) today announced that Forest Laboratories Holdings...
Published on Wednesday 8th of February 2012 01:03:03 PM
Read more...
Business Wire - NMS Labs launches pain management lab test for Milnacipran, a new drug approved by the FDA for the treatment of Fibromyalgia pain
Posted by admin / Under MilnacipranMarch 30, 2010 -- NMS Labs provides more innovative tests for pain management.
WILLOW GROVE, Pa. -- NMS Labs launches another unique test suitable for...
Published on Wednesday 8th of February 2012 01:03:03 PM
Read more...
